Programmed activation of cancer cell apoptosis: A tumor-targeted phototherapeutic topoisomerase I inhibitor

Weon Sup Shin, Jiyou Han, Rajesh Kumar, Gyung Gyu Lee, Jonathan L. Sessler, Jong-Hoon Kim, Jong Seung Kim

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We report here a tumor-targeting masked phototherapeutic agent 1 (PT-1). This system contains SN-38 - a prodrug of the topoisomerase I inhibitor irinotecan. Topoisomerase I is a vital enzyme that controls DNA topology during replication, transcription, and recombination. An elevated level of topoisomerase I is found in many carcinomas, making it an attractive target for the development of effective anticancer drugs. In addition, PT-1 contains both a photo-triggered moiety (nitrovanillin) and a cancer targeting unit (biotin). Upon light activation in cancer cells, PT-1 interferes with DNA re-ligation, diminishes the expression of topoisomerase I, and enhances the expression of inter alia mitochondrial apoptotic genes, death receptors, and caspase enzymes, inducing DNA damage and eventually leading to apoptosis. In vitro and in vivo studies showed significant inhibition of cancer growth and the hybrid system PT-1 thus shows promise as a programmed photo-therapeutic ("phototheranostic").

Original languageEnglish
Article number29018
JournalScientific Reports
Volume6
DOIs
Publication statusPublished - 2016 Jul 4

Fingerprint

Topoisomerase I Inhibitors
irinotecan
Type I DNA Topoisomerase
Apoptosis
Neoplasms
Death Domain Receptors
Mitochondrial Genes
DNA
Prodrugs
Enzymes
Biotin
Caspases
Genetic Recombination
DNA Damage
Ligation
Carcinoma
Light
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • General

Cite this

Programmed activation of cancer cell apoptosis : A tumor-targeted phototherapeutic topoisomerase I inhibitor. / Shin, Weon Sup; Han, Jiyou; Kumar, Rajesh; Lee, Gyung Gyu; Sessler, Jonathan L.; Kim, Jong-Hoon; Kim, Jong Seung.

In: Scientific Reports, Vol. 6, 29018, 04.07.2016.

Research output: Contribution to journalArticle

Shin, Weon Sup ; Han, Jiyou ; Kumar, Rajesh ; Lee, Gyung Gyu ; Sessler, Jonathan L. ; Kim, Jong-Hoon ; Kim, Jong Seung. / Programmed activation of cancer cell apoptosis : A tumor-targeted phototherapeutic topoisomerase I inhibitor. In: Scientific Reports. 2016 ; Vol. 6.
@article{0a6bbb61ab174b4fa00d39f4f95d28d9,
title = "Programmed activation of cancer cell apoptosis: A tumor-targeted phototherapeutic topoisomerase I inhibitor",
abstract = "We report here a tumor-targeting masked phototherapeutic agent 1 (PT-1). This system contains SN-38 - a prodrug of the topoisomerase I inhibitor irinotecan. Topoisomerase I is a vital enzyme that controls DNA topology during replication, transcription, and recombination. An elevated level of topoisomerase I is found in many carcinomas, making it an attractive target for the development of effective anticancer drugs. In addition, PT-1 contains both a photo-triggered moiety (nitrovanillin) and a cancer targeting unit (biotin). Upon light activation in cancer cells, PT-1 interferes with DNA re-ligation, diminishes the expression of topoisomerase I, and enhances the expression of inter alia mitochondrial apoptotic genes, death receptors, and caspase enzymes, inducing DNA damage and eventually leading to apoptosis. In vitro and in vivo studies showed significant inhibition of cancer growth and the hybrid system PT-1 thus shows promise as a programmed photo-therapeutic ({"}phototheranostic{"}).",
author = "Shin, {Weon Sup} and Jiyou Han and Rajesh Kumar and Lee, {Gyung Gyu} and Sessler, {Jonathan L.} and Jong-Hoon Kim and Kim, {Jong Seung}",
year = "2016",
month = "7",
day = "4",
doi = "10.1038/srep29018",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Programmed activation of cancer cell apoptosis

T2 - A tumor-targeted phototherapeutic topoisomerase I inhibitor

AU - Shin, Weon Sup

AU - Han, Jiyou

AU - Kumar, Rajesh

AU - Lee, Gyung Gyu

AU - Sessler, Jonathan L.

AU - Kim, Jong-Hoon

AU - Kim, Jong Seung

PY - 2016/7/4

Y1 - 2016/7/4

N2 - We report here a tumor-targeting masked phototherapeutic agent 1 (PT-1). This system contains SN-38 - a prodrug of the topoisomerase I inhibitor irinotecan. Topoisomerase I is a vital enzyme that controls DNA topology during replication, transcription, and recombination. An elevated level of topoisomerase I is found in many carcinomas, making it an attractive target for the development of effective anticancer drugs. In addition, PT-1 contains both a photo-triggered moiety (nitrovanillin) and a cancer targeting unit (biotin). Upon light activation in cancer cells, PT-1 interferes with DNA re-ligation, diminishes the expression of topoisomerase I, and enhances the expression of inter alia mitochondrial apoptotic genes, death receptors, and caspase enzymes, inducing DNA damage and eventually leading to apoptosis. In vitro and in vivo studies showed significant inhibition of cancer growth and the hybrid system PT-1 thus shows promise as a programmed photo-therapeutic ("phototheranostic").

AB - We report here a tumor-targeting masked phototherapeutic agent 1 (PT-1). This system contains SN-38 - a prodrug of the topoisomerase I inhibitor irinotecan. Topoisomerase I is a vital enzyme that controls DNA topology during replication, transcription, and recombination. An elevated level of topoisomerase I is found in many carcinomas, making it an attractive target for the development of effective anticancer drugs. In addition, PT-1 contains both a photo-triggered moiety (nitrovanillin) and a cancer targeting unit (biotin). Upon light activation in cancer cells, PT-1 interferes with DNA re-ligation, diminishes the expression of topoisomerase I, and enhances the expression of inter alia mitochondrial apoptotic genes, death receptors, and caspase enzymes, inducing DNA damage and eventually leading to apoptosis. In vitro and in vivo studies showed significant inhibition of cancer growth and the hybrid system PT-1 thus shows promise as a programmed photo-therapeutic ("phototheranostic").

UR - http://www.scopus.com/inward/record.url?scp=84977269769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977269769&partnerID=8YFLogxK

U2 - 10.1038/srep29018

DO - 10.1038/srep29018

M3 - Article

C2 - 27374023

AN - SCOPUS:84977269769

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 29018

ER -